Table: RaQualia Pharma -2023 group results

RaQualia Pharma

14/02/2024 06:30

Feb 14 (Reuters)- 
          RaQualia Pharma Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2023    Dec 31, 2022   Dec 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             1.90            2.92           4.54                  
                 (-34.8 pct)     (+5.1 pct)    (+138.5 pct)              
  Operating     loss 337 mln       866 mln        313 mln                
                                 (+22.4 pct)                             
  Recurring     loss 293 mln       904 mln        290 mln                
                                 (+4.7 pct)                              
  Net
  Net           loss 323 mln       723 mln        236 mln                
                                 (-4.3 pct)                              
  EPS          loss 14.98 yen     34.50 yen      10.91 yen               
  EPS Diluted                     34.47 yen                              
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - RaQualia Pharma Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T